SARAH FABER-CATANESE: Open Payments
NPI 1205313913 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,859 in 103 payments from 19 companies in 2025. Trend: 2023 $23,103 · 2024 $4,624 · 2025 $2,859
Food & beverage: $2,859
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $765 |
| E.R. Squibb & Sons, L.L.C. | 13 | $502 |
| ABBVIE INC. | 13 | $313 |
| Alkermes, Inc. | 6 | $206 |
| Neurocrine BioSciences, Inc. | 10 | $182 |
| Axsome Therapeutics, Inc. | 9 | $170 |
| Janssen Pharmaceuticals, Inc | 6 | $132 |
| Supernus Pharmaceuticals, Inc. | 4 | $112 |
| Otsuka America Pharmaceutical, Inc. | 6 | $111 |
| Biogen, Inc. | 1 | $100 |
Products named: CAPLYTA, COBENFY, VRAYLAR, ARISTADA, INGREZZA, Auvelity, Qelbree, ZURZUVAE.
Industry payments across VA — which companies pay providers there.
